Adipokines and Inflammation: Focus on Cardiovascular Diseases
It is well established that adipose tissue, apart from its energy storage function, acts as an endocrine organ that produces and secretes a number of bioactive substances, including hormones commonly known as adipokines. Obesity is a major risk factor for the development of cardiovascular diseases,...
Main Authors: | Sandra Feijóo-Bandín, Alana Aragón-Herrera, Sandra Moraña-Fernández, Laura Anido-Varela, Estefanía Tarazón, Esther Roselló-Lletí, Manuel Portolés, Isabel Moscoso, Oreste Gualillo, José Ramón González-Juanatey, Francisca Lago |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/20/7711 |
Similar Items
-
Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases
by: Alana Aragón-Herrera, et al.
Published: (2022-06-01) -
Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models
by: Sandra Feijóo-Bandín, et al.
Published: (2022-05-01) -
The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile
by: Alana Aragón-Herrera, et al.
Published: (2022-02-01) -
The Adipokine Chemerin Induces Apoptosis in Cardiomyocytes
by: Diego Rodríguez-Penas, et al.
Published: (2015-08-01) -
Relaxin-2 in Cardiometabolic Diseases: Mechanisms of Action and Future Perspectives
by: Sandra Feijóo-Bandín, et al.
Published: (2017-08-01)